Coronavirus disease (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in December 2019. In response to the evolving pandemic, the international research evidence base is rapidly expanding.
HIQA has established a COVID-19 Evidence Synthesis Team within its Health Technology Assessment (HTA) Directorate. With the support of its Expert Advisory Group (EAG), the team is conducting evidence synthesis to inform national strategic decision-making. These evidence syntheses are performed at the request of the Department of Health, the COVID Advisory Group and groups tasked with the national COVID-19 response. This work helps ensure rapid access to the best available evidence relevant to SARS-CoV-2 to inform decision-making at each stage of the pandemic.
Click here for an overview of our COVID-19 evidence synthesis process.